Impact of antenatal corticosteroid therapy on neonatal respiratory outcomes in late preterm births
- PMID: 40760723
- PMCID: PMC12320321
- DOI: 10.1186/s12887-025-05925-w
Impact of antenatal corticosteroid therapy on neonatal respiratory outcomes in late preterm births
Abstract
Objective: This study aimed to evaluate the impact of antenatal corticosteroid therapy (ACT) on neonatal respiratory outcomes in late preterm births, focusing on the interaction between gestational age, mode of delivery, and ACT administration.
Methods: A retrospective case-control study was conducted on 452 singleton late preterm pregnancies (34 + 0 to 36 + 6 weeks) between 2014 and 2021. Among these, 197 patients received ACT, while 255 did not. Maternal and neonatal characteristics were collected, and logistic regression analyses were performed to identify predictors of neonatal respiratory complications.
Results: ACT was associated with a 42% reduction in the odds of neonatal pulmonary complications (adjusted OR: 0.586; 95% CI: 0.347–0.988; p = 0.045). Gestational age was a significant protective factor, with each additional week reducing the risk of adverse pulmonary outcomes by 60% (adjusted OR: 0.397; 95% CI: 0.281–0.561; p < 0.001). Cesarean delivery was associated with a nearly fourfold increase in pulmonary complications compared to vaginal delivery (adjusted OR: 3.775; 95% CI: 1.859–7.666; p < 0.001). ACT showed the most significant protective effect in earlier gestational weeks and among cesarean deliveries.
Conclusion: ACT was associated with reduced neonatal pulmonary complications in late preterm pregnancies, particularly among subgroups with earlier gestational age or cesarean delivery, as supported by multivariate and interaction analyses. These findings underscore the importance of individualized antenatal and perinatal management strategies to optimize neonatal outcomes.
Keywords: Antenatal corticosteroids; Cesarean delivery; Late preterm birth; Neonatal respiratory outcomes.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of Etlik Zübeyde Hanım Women’s Health Training and Research Hospital (Protocol ID: 01/2021-01-19). Written informed consent was obtained from all participants. Additionally, informed consent for the use of neonatal data was obtained from the parents or legal guardians of all newborns included in the study. The data were anonymized and handled in compliance with ethical guidelines to ensure participant confidentiality. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Impact of antenatal corticosteroid therapy on neonatal outcomes in twin pregnancies.J Transl Med. 2025 Jul 3;23(1):739. doi: 10.1186/s12967-025-06679-w. J Transl Med. 2025. PMID: 40611291 Free PMC article.
-
Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes.Am J Obstet Gynecol MFM. 2021 Sep;3(5):100426. doi: 10.1016/j.ajogmf.2021.100426. Epub 2021 Jun 18. Am J Obstet Gynecol MFM. 2021. PMID: 34153514
-
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Dec 25;12:CD004454. doi: 10.1002/14651858.CD004454.pub4. PMID: 28321847 Free PMC article. Updated.
-
Long-Term Neurodevelopmental Outcomes After Antenatal Corticosteroid Therapy in Late Preterm Twins: A Nationwide Retrospective Cohort Study.J Korean Med Sci. 2025 Aug 4;40(30):e174. doi: 10.3346/jkms.2025.40.e174. J Korean Med Sci. 2025. PMID: 40762591 Free PMC article.
-
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4. Cochrane Database Syst Rev. 2021. PMID: 34935127 Free PMC article.
References
-
- Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–61. - PubMed
-
- Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–72. - PubMed
-
- Raju TNK, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118(3):1207–14. - PubMed
-
- Delnord M, Zeitlin J. Epidemiology of late preterm and early term births - an international perspective. Semin Fetal Neonatal Med. 2019;24(1):3–10. - PubMed
-
- Committee on Obstetric Practice. Committee opinion 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102–9. - PubMed
LinkOut - more resources
Full Text Sources